Molecular & Precision Medicine Tri-Con 2022 Attended by 450 Unique Organizations In-Person and Virtual
This year the Molecular & Precision Medicine Tri-conference was attended by more than 800 people. Participants gathered in-person and virtually over 3 days to discuss the latest research and technologies in precision medicine and precision health; innovation in point-of-care and molecular diagnostics and market access strategies; advanced diagnostics for COVID-19 and other infectious diseases; precision oncology diagnostics and therapeutics; liquid biopsy and minimal residual disease testing; biomarkers and companion diagnostics; and new technologies for spatial multi-omic analysis.
The impressive audience at Molecular Medicine Tri-conference came together for invaluable networking opportunities with more than 50% of the attendees titled as a decision-maker from leading Biotech companies (55%) and Healthcare (16%). Industry leaders and key decision-makers representing 29 different countries and more than 450 unique organizations shared case studies, collaborated on best practices, and provided unique perspectives on poignant issues that the field currently faces.
Mark your calendar for 2023
30th Annual Molecular Medicine Tri-conference 2023
March 6-8, 2023
Hilton San Diego Bayfront
San Diego, California
“A must to learn about the future of personal medicine and diagnostics”
- Ernst L., Director R&D, Future Diagnostics
- Saira B., Lecturer, Jinnah University for Women
"Great conference with very inspiring presentations"
- Vincent M., Head, Sanofi R&D
"Great opportunity to discuss with pharma/biotech in this venue"
- Dave H., Professor & Director, Saint Johns Cancer Institute
"Networking with fellow professionals is fundamental for innovation to happen. Attending TriCon gives me a networking boost for the rest of the year"
- Juan R., VP Business Development, Veranex/Ximedica
“The virtual platform was easy to navigate, and it was simple to connect with other attendees. The content of the talks was relevant and interesting!”
- Vanessa L., Staff Scientist Molecular Biology, Thermo Fisher Scientific
"This conference is one of a kind! The topics and speakers are so incredibly unique!"
- Michael K., Professor, Ferris State University
"Tri-Con is to me the best event to dig into the relationships between the pharmaceutical and diagnostics industry. Clinical biomarkers are at the heart of precision medicine and this event brings together the communities that make it possible"
- Marianne M., Mgr., Business Development, Alcediag
"TriCon takes you from the theoretical to the practical"
- Dwight E., CEO, Co-diagnostics Inc.